Hello User
Sign in
Hello
Sign Out
My Account My Account
Data Insights
Top Sections
Premium Offerings
Tools and Calculators
MultiMedia Collections
More From Mint
Explore Mint
Copyright © HT Digital Streams Limited
All Rights Reserved.
Sign In
Subscribe

Get Your Credit Score For Free

Check Now
Next Story
Business News/ Companies / News/  Merck says its COVID-19 drug should be effective against any variant

Merck says its COVID-19 drug should be effective against any variant

Manas Mishra , Reuters

Merck says its molnupiravir drug, developed along with Ridgeback Biotherapeutics, shows antiviral properties against coronavirus variants such as the Delta variant

A file photo of Merck's experimental COVID-19 drug molnupiravir

BENGALURU :Merck & Co Inc's experimental COVID-19 drug molnupiravir should have similar activity against any new coronavirus variant, a company executive said on Tuesday.

The drug, developed along with Ridgeback Biotherapeutics, shows antiviral properties against coronavirus variants such as the Delta variant, Daria Hazuda, vice president of Merck's infectious diseases and vaccines division, said.

Hazuda's comments were part of a general presentation and not specific to the Omicron coronavirus variant.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
Get the latest financial, economic and market news, instantly.